The human cytomegalovirus (CMV) is one of the common viral infections worldwide that represent a major cause of congenital infections. To determine the seroprevalence of CMV in women with bad obstetric history and sociodemographic characteristics that may influence the seropositivity, a case control descriptive prospective study was conducted in Kirkuk, Iraq. A 838 women with age range from 14 to 48 were included in the study. Of the total, 547 women were with bad obstetric history (BOH) and 291 women with normal previous pregnancy as control group. All the serum samples collected from the study and control groups were tested for CMV IgM and IgG antibodies by ELISA kits. CMV IgM seroprevalence was higher in women with BOH. CMV IgG seroprevalence was with no significant difference between BOH and control. CMV IgG seroprevalence significantly influenced by age, education, smoking, and family size. However, CMV IgM seroprevalence significantly associated with pregnancy, residence, and animal exposure. Odd ratio confirmed the association between CMV IgG and age, crowding index, residence, smoking, and number of abortion in women with BOH. In addition, current CMV infection significantly associated with residence in women with BOH.
INTRODUCTION
The human cytomegalovirus (HCMV) is the most common congenital viral infection worldwide and may be asymptomatic forms (90% of cases) to severe fetal damage and, in rare cases, death due to abortion [1] . Cytomegalovirus (CMV) infection during pregnancy is far more complex than other infections, due to the ability of the virus to be frequently reactivated during the child bearing age and be transmitted to the fetus inspite of maternal immunity [2] . HCMV infection was a complex phenomenon since the virus act as an immune modulator through elaborating an array of immune evasion strategies to avoid elimination from the host, and its viral proteins an involved in the regulation of cellular gene expression and induction of proinflammatory cytokine [3] or induction of autoimmune status [4] .
There are many confounding studies about the association between CMV infection and pregnancy loss; the studies showed that HCMV can result in abortion or stillbirth [5] , [6] . Cytomegalovirus is frequently Table 2 . There were a significant differences in CMV IgG seroprevalence between pregnant and non pregnant women in BOH (X 2 =6.82, P=0.007) and control (X 2 =6.76, P=0.008) groups. However, such pattern was demonstrated in control group for CMV IgM (X 2 =14.64, P=0.000) seroprevalence, Table 2 . There was a non significant difference (X 2 =0.6, P>0.05) in CMV IgG seroprevalence between pregnant (92.8%) and non-pregnant (91.4%) women. In addition, current infection as demonstrated in IgM positivity was significantly higher (X 2 =6.85, P=0.007) in pregnant women (5.8%) as compared to nonpregnant (2.2%) women. Table 3 .
Age significant seroprevalence variation was demonstrated for CMV IgG in both BOH (X 2 =9.21, P=0.027) and control (X 2 =20.5, P=0.000). In BOH group, CMV IgG seropositivity was 95.6% in women with age of < 20 years, then declined in women with age. While in control group seropositivity was 100% in women with age of <20 and then decline in women with age of 20-29 years, but subsequently increased to reach 100% in women with age of 40 -48 years. CMV IgM seroprevalence was lowest in women with 30-39 years age (3.3%), and highest (4.6%) in women with age of 14 -29 years. However, in control CMV IgM was detected in women with 20-29 years of age (10.3%). In addition, there was a significant (P=0.03) higher CMV IgM seroprevalence (10.3%) in control as compared to women with BOH (4.6%) in the age of 20 to 29 years. While in the age group 30 -39 years, CMV IgM was significantly higher (P=0.007) in women with BOH (3.3%) as that in control (0%), Table 4 .
CMV IgG seroprevalence was with significant differences between control and women with BOH. The seroprevalence rate was significantly (P=0.007) lower in control (86.6%) as compared to women with BOH (94.6%) with age of 20-29 years, while with reverse pattern for the age groups of 30-39 (control ,98.9%; BOH, 87.4%, p=0.002) and 40-48 years (control ,100%; BOH, 87.4%, p=0.038). Table 4 .
The CMV IgM seroprevalence was higher in women with age of < 30 years (4.2%) as compared to those > 30 years (3.4%), but the difference not reach a significant level (X 2 =0.22, P=>0.05). While in the control group the rate also higher in women <30 years (7.5%) as compared to those >30 years (0%, X 2 =9.28, P=0.002), Table 5 . OR also not confirmed a significant association between age of <30 years and CMV IgM (OR=0.81,P>0.05), Table 6 . The CMV IgG seroprevalence was significantly (X 2 =9.17, P=0.003) higher in BOH women of <30 years (94.7%) than those of >30 years (87.4%). While in the control group, it was significantly higher (X 2 =9.75, P=0.002) in women with age >30 years (99.2%), Table 5 . OR confirmed the association between age of <30 years and CMV IgG (OR=2.594, P=0.003) seropositivity, while CMV IgM seropositivity was associated with age of <30 years (OR=2.38,P=0.028) when data of BOH and control collected together. In women with age of >30 years, there were a significant differences between BOH and control group in CMV IgM seroprevalence (X 2 =4.15, P=0.042) and CMV IgG seroprevalence (X 2 =13.8, P=0.000), Tables 5 & 6 .
Women living in rural areas demonstrate 92% seropositivity for CMV IgG, while in urban area the seropositivity was 90.9%, with no significant difference (X 2 =0.169,P>0.05). However, current infection was significantly (X 2 =10.18, P=0.000) higher in women from urban (5.6%) areas as it was not detected in women from rural (0%) areas, 
Discussion
The present study shows a high CMV IgG overall seroprevalence (92.1%), with no significant differences between rate in women with BOH and that with normal pregnancy. Thus the susceptibility rate in our study population was 7.9%, which was higher to that reported recently for Turkey [11] , [17] - [22] , Nigeria [23] , [24] , Brazil [25] , Iran [26] , [27] , Bangladesh [28] , Korea [29] , and Cuba [30] . However, our study susceptibility was lower than that reported for France [31] , Nepal [32] , India [13] , [33] , [34] , Switzerland [35] , Croatia [36] , Malaysia [37] , Iran [12] , [38] , Poland [39] , Ireland [10] , Russia [40] , Taiwan [41] , Germany [42] , Azerbaijan [43] , Bangladesh [44] , and Brazil [45] . In comparison to Arab countries, this study susceptibility rate was lower to that reported for Egypt [46] , Sudan [47] , Syria [48] , and Jordan [15] , but similar to that reported for Saudi Arabia [49] , and higher to rate in Qatar [50] , Sudan [51] , and Tunisia [52] .
The comparison with Iraqi studies, this study was with higher rate to that reported for Kirkuk [53] , but was lower to that reported for Baghdad , Waset, Al-Anbar, Al-Hila, Thi Qar, Kirkuk, Diwaniya, and Babylon [54] , [14] , [15] , [55] - [61] . However, the mostly deviated rates were that reported for Kirkuk [59] , Baghdad [16] and Thi Qar [62] , which they reported a very low seroprevalence rate of CMV.
In the present study and in that reported globally show a high seroprevalence of CMV IgG antibodies, however, this preconceptional immunity against CMV provide incomplete protection against intrauterine transmission, and adverse outcomes can occur in infected children born to women who were seropositive prior to pregnancy [63] - [67] . Transplacental transmission of CMV in women with preexisting seroimmunity may be a secondary to virus reactivation [68] or to infection with a new different CMV strain (reinfection) [69] during pregnancy.
Previous immunization with CMV is not perfectly protective against either reinfection or vertical transmission of infection from mother to fetus [20] , [23] . In a recent study, approximately one third of the study seroimmune women were noted to have CMV reinfection during follow up [69] . A recent review of the literature indicated that the incidence of congenital CMV infection increases with increasing maternal CMV seroprevalence [68] . The positive correlation between higher maternal seroprevalence and high birth prevalence may seem paradoxical because this suggests that a smaller number of pregnant women are at risk for primary infection. However, in a high seroprevalence population, the number of pregnancies at risk for reactivation is also increased. In addition, the high seroprevalence may be due to a higher prevalence of risky behaviors in the population. In a high seroprevalence population, a pregnant woman has a higher likelihood of exposure to CMV-infected people. Thus, in a high risk population, seropositive women have a higher risk of reactivation and seronegative women have a higher risk of primary infection [70] . Preventive measures should be taken to decrease perinatal mortality and morbidity related to CMV infection and to ensure that women are not infected with CMV during pregnancy. Pregnant women should be consulted and encouraged to implement these preventive measures. Routine nationwide screenings for this condition should be considered, although serious cost effectiveness issues need to be evaluated before the implementation of such screenings.
In Kirkuk, CMV seroprevalence is as high as 92.1%. Routine CMV screening in such a population is unnecessary, but there are exceptions. Pregnant women who had contact with a patient with a proven acute CMV-IgG seroprevalence among our study population women ranged from 87.4% to 95.6% across age groups and shows a significant trends with age (X 2 =9.21, P=0.027). However, there was a significant (X 2 =4.32-9.51, P=0.038-0.002) differences in seroprevalence between women with BOH and control among the age groups of 20-29,30-39,qnd 40-48. In addition, the women in the age group 30 and above years old had lower prevalence CMV-IgG (87.4%, 229/262) as compared to women in the age of <30 years (94.7%,270/285). This difference was significant as confirmed by OR calculation (OR=2.594, P=0.003). This trend was not consistent to a recently reported study in Kirkuk in which the rate was higher in women with age of >30 years [53] . The difference between the two studies was due to that the present study included only BOH group, while the recently reported study include BOH and control collected together. The CMV transmission variation in different age groups could be due to fact that as the women interaction and encounter with the risk factors tend to increase or decrease according to age [72] and social characters. Our finding was in consistent to that reported for other geographical areas [20] , [47] , [72] , [73] , [74] . Seroprevalence for CMV between the age of 15 to 19 years was too high (95.6%). This high seroprevalence could be attributed to the widely practice of breastfeeding during infancy [75] . Breastfeeding is a common practice in Iraq and it is known to be a significant source of CMV transmission to children and plays an important role in the epidemiology of CMV infection as the virus is reactivated during lactation in nearly every seropositive mother [76] . In addition, close contacts and crowdness in the primary and secondary schools could contribute to such increase in CMV seroprevalence [77] . The antibody prevalence reduced (94.6%) in the age group of 20 -29 years. This finding was not agreed to that reported for USA, in which seroprevalence increased steadily with age [78] , but agreed with that reported for Portugal [74] . Studies with similar age groups conducted in other countries, such as USA, Japan, France, England, Poland, and Russia, describe seroprevalences ranging between 51.5% and 78% [40] , [79] - [84] .
The seroprevalence of women with CMV-IgG gradually reduced in the two oldest age groups, with values of 87.4% and 87.5%, suggesting that sexual transmission was an important route of transmission of the virus in the population [85] . Another recognized source of adult CMV infection are children. CMV infected children shed virus in saliva and urine for years, providing an opportunity for continued spread to other children and susceptible adults (close relative, teachers) [86] , [87] .
Nevertheless, it should be noted that in our study, 7.2 % of the pregnant women were susceptible to CMV, a finding that was not significantly different from that recently reported (6.5%) for Kirkuk [53] . In addition, 5.8% of pregnant women was with current infection, which let us to conclude that there is a considerable risk for congenital infection due to maternal primary CMV infection, which leads to fetal infection in approximately 40% of cases (6% congenital infection in our cohort) [88] . However, this rate of current infection was lower to that reported for Kirkuk (9.6%) recently, which indicating a reduction in primary CMV infection. In this risk group (women with primary CMV), we must apply the approaches to prevent congenital CMV infections, which include improved hygiene behavior, of seronegative women, administration of hyperimmune globulin to pregnant women with primary infection or pregnant women with previous infection who demonstrated CMV antibody titers or low IgG avidity [89] .
Child-to-mother transmission of CMV during pregnancy in seronegative women could be controlled or prevented through simple hygiene such as frequent hand washing, wearing gloves for specific childcare tasks and avoiding intimate contact with their child such as sharing utensils, food or towels, and kissing on or near mouth [90] - [92] .
Despite advances in the diagnosis of maternal-fetal CMV infection and approaches to prevent congenital CMV, an effective prenatal therapy is unavailable. A prospective, non-randomised study of pregnant women who acquired CMV infection during pregnancy and who received passive immunisation with CMV HIG, showed that this therapy was associated with a significantly reduced risk of congenital CMV disease and infection and had no adverse effects [89] , [93] , [94] . Recent case reports supported safe administration of oral ganciclovir to mothers of CMV-infected fetuses, with no teratogenic side effects when given in the early stages of pregnancy [89] , [95] , [96] . The efficacy of ganciclovir still remains to be defined in controlled trials. Other early experience with treatment of intrauterine CMV infection using maternal oral administration of valaciclovir showed that it decreased the viral load in fetal blood significantly and could potentially also reduce the morbidity of prolonged intrauterine infection [97] . The absence of adverse effects or teratogenecity of valaciclovir is compatible with its clinical use, but a well designed randomised controlled trial is needed. Currently, there is no approved vaccine for CMV, but two vaccines are in phase II studies: one is a recombinant vaccine containing the major envelope glycoprotein B of the virus with the adjuvant MF59 (gB/MF59) that induces high levels of neutralising antibodies, is safe and immunogenic in adults and infants, preventing also maternal CMV infection [98] , [99] . The other vaccine is the live attenuated CMV Towne strain that stimulates neutralising antibodies comparable to those induced by wild type virus and protects renal transplant patients from severe CMV after transplantation [93] , [100] .
The main interventions for the prevention of CMV infection should be aimed at women who wish to become pregnant, women who care for children and immunocompromised individuals. These individuals in whom exposure to CMV can be most detrimental will be the target groups for possible administration of a future vaccine [74] .
From this study, rural residents had the higher CMV-IgG prevalence of 92%, while urban residents CMV -IgG seroprevalence was 90.9% (X 2 =0.169, P>0.05). The association between CMV-IgG seroprevalence and residence was not confirmed by OR calculation (OR=0.872,P>0.05) which not agrees with the statement that low socio-economic status has been found as a strong risk factor for acquisition of CMV infection [101] . Our finding was in agreement with that reported recently for Kirkuk [53] and that reported for other geographical areas [72] , [102] .
In relation to educational status, CMV-IgG seroprevalence was significantly lower in uneducated (86.6%) as compared to educated women (92.8%) (X 2 =4.33, P=0.037). OR confirm the association between CMV-IgG seroprevalence and educated women (OR=2.003, P=0.026). This finding was not in agreement to that reported for other countries [47, 72] [41, 60] and recently reported for Kirkuk [53] . Illiteracy and low education levels were observed before as risk factors for increased susceptibility to acquisition of CMV infection, perhaps through the direct contact with contagious secretions from their own children and poor hygiene practiced by these women [101] ,[103]- [105] .
Likewise, low socioeconomic status has been found as a strong risk factor for acquisition CMV infection [101] . Nevertheless in Iraq it is difficult to investigate the socio-economic status of these pregnant women because the culture is based on generous hospitality attitude toward guest and family members who usually lives in extended families [53] .
There was no difference in prevalence of CMV-IgG amongst working women (91.1%) as compared to housewife (91.2%) women. Using bivariate analyses, OR not confirmed a significant association between occupation and CMV-IgG seroprevalence. This finding agreed to that reported by others [53] , [72] . In contrast, a reported study indicated that CMV-IgG seropositivity was more in housewife women occupation as compared to others [44] .
The present study shows a lower CMV-IgG seroprevalence in large size families (crowding index >3) (75.2%), than that in small size families (98.2%) (X 2 =73.4, P=0.000). OR confirmed the association between crowding index and CMV-IgG seropositivity (OR=17.713,P=<0.0001) a finding not agreed to that reported by others [53] , [104] . Housing crowdedness and family size are imperfect measures of the transmission dynamics that actually determine an individual's risk of exposure [105] . No significant association was found between the prevalence of BOH due to CMV infection and a mean household size of more than 3.0 persons. Previous studies suggest a positive correlation of congenital CMV with a household size more than three persons and low socioeconomic status [87] , [106] - [108] .
CMV IgM seroprevalence among women included in this study was 4.1% and vary significantly between pregnant (5.8%) and non pregnant (2.2%) women (X 2 =6.85, P=0.007). Although, CMV IgM seroprevalence was lower in women with bad obstetric history (3.8%) as compared to women with normal pregnancy (4.5%), but the difference was not significant. However, current infection of 4.1% and 7.2% seronegative in pregnant women represent a high rate of hazard for foetal infection. The current infection was lower (4.1%) than that reported recently (6.3%) for Kirkuk [53] indicating a decline in transmission of the virus in studied population.
Globally reported CMV IgM seropositivity range was from 0% for Turkey [19] to 13% for Poland [39] in pregnant women and from 0% for India [33] to 8.42% for India [13] . In Arab countries, the range of CMV IgM seropositivity was from 2.3% for Jordan [15] to 57.2 for Babylon, Iraq [14] in pregnant women, while to range in women with BOH was from 1.4% for Jordan [15] to 60.2% for Waset, Iraq [54] . Thus the present study finding for both women with normal pregnancy (4.5%) and with BOH (3.8%) lay within the reported ranges for global areas and for Arab countries. However, the current CMV infection in our study IJPHS ISSN: 2252-8806 
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37 was lower to that reported for Waset [54] , Babylon [14] , Diwaniya [61] , Mosul [109] , Baghdad [55] , [60] , [110] , Al-Hila [56] , Thi Qar [58, 62] and Kirkuk [59] , [53] . CMV IgM seroprevalence varied by age (X 2 =0.88, P>0.05), with a highest rate of current infection (4.2%) in younger age (<30 yrs) as compared to elder (>30 yrs)(3.4%, X 2 =0.22, P>0.05). This finding agreed with previous studies which showed that elderly persons seem to be well protected against CMV infection due to accumulation of CD28 effector cytotoxic T lymphocytes [72] . This is a characteristic feature of all age groups but is most pronounced in elderly persons [111] . However, there is a lot of debate concerning maternal age and CMV infection; while many investigators observed that, elder women were at higher risk of CMV infection [72] , [101] , others reported the reverse [30] or absence of variation by age [78] . All of the above findings are consistent with the understanding that CMV IgM can be produced throughout life after primary infection or as a result of reinfection or reactivation [112] , [13] , and suggest that in some older cohorts may be as likely to have a recurrent episodes as younger people are to have a primary infection [78] .
The present study finding indicated a significant differences in recent infections between control and women with BOH, who were with age of 20-29 (X 2 =4.43, P=0.03) and 30 -39 (X 2 =7.3, P=0.007). this findings could be attributed to the age of marriage in Iraq (around 20 years) and sexual activity.
Risk factors based on residence (OR=29.71,P=0.01), emerged for CMV IgM seroprevalence in contrast to education, age, crowding index, occupation, smoking, haemoglobin level, animal exposure, number of abortion and congenital anomalies. Staras et al [79] not reported age as a risk for CMV IgM seropositivity, but confirmed the age as risk for CMV IgG seropositivity. The lack of identifiable risk factors for CMV IgM may be due to relatively low number of observations, and because over 80% of the IgM reactivity in tested sample was with high avidity and thus presumably from non primary CMV infection, which may be less associated with identifiable risk than primary infection [78] . In addition, a portion of the IgM positive sera may have been false positive determinations known to occur with CMV IgM testing [114] .
The current CMV infection was more predominant in urban women (5.6%;X 2 =10.18, P=0.000)), and this finding was agreed to that reported for Kirkuk [53] and not consistent with previously reported studies [72] , [110] , [115] . In addition, there were no significant differences in current CMV infection in regards to occupation, education, family size, smoking, haemoglobin level, number of abortion and congenital anomalies as OR was not significant. However, current infection was with significant differences between who exposed to animal and not exposed women (X 2 =8.99, P=0.001). Kolo et al [72] reported a high prevalence of CMV IgM in pregnant women with primary education, which agrees with the reports from United States and Western Europe.
The present study indicated a high CMV IgG seroprevalence (94.2%) in women with BOH who were smoking (X 2 =8.93, P=0.003) as compared to non smoking (86.8%). OR confirmed that smoking was a risk factor for development of BOH in women infected previously with CMV. This could be explained on the basis that smoking may reactivate the latent CMV infection, a hypothesis that need a future research to confirm such association. Cigarette smoke was shown to augment the production of numerous proinflammatory cytokines and to decrease the levels of anti-inflammatory cytokines [116] - [118] . In addition, smoking may play a role in the process of autoimmune disorders as reported in rheumatoid arthritis and systemic lupus erythematosus [117] , this phenomenon could be present in cases of abortion.
Most of the reported studies have addressed the risk of spontaneous abortion in relation to smoking during pregnancy, however, results are not entirely consistent [119] , [120] . The amount of daily smoking prior to pregnancy seems to be associated with an increased risk of spontaneous abortion, where as the duration of smoking does not seem to be related to an increased risk of spontaneous abortion [120] . The present study demonstrated a significant association between presence of CMV IgG positivity and smoking. Thus smoking could be a risk factor for CMV infection. However, this need to be evaluated in a study that take in consideration the amount of smoking.
This study shows a higher (92.1%) CMV IgG seroprevalence in BOH women with haemoglobin level of <11 as compared to those with haemoglobin of >11(90.9%), but the difference was not significant (X 2 =0.06, P>0.05). OR not confirmed that iron deficiency anaemia as risk factor for BOH development in women infected with CMV. Anemia is a global public health problem. It has serious short-and long-term consequences during pregnancy and beyond. The anemic condition is often worsened by the presence of other chronic diseases . Untreated anemia also leads to increased morbidity and mortality from these chronic conditions as well [121] . In the present study we are not sure whether the anaemia was a consequence of the CMV chronicity or the anaemia may be a risk factor for the development of CMV infection. This could be evaluated in a follow up study during pregnancy of a negative CMV pregnant.
The exact mechanism by which anemia is caused in chronic inflammatory conditions is unknown. A common factor may be the contribution of hepcidin, a polypeptide hormone. Chronic inflammatory conditions lead to release of cytokines from the reticuloendothelial system as a part of cell-mediated immunity. In response to these cytokines, mainly interleukin 6 (IL-6) [122] , [123] , the liver produces 38 increased amounts of hepcidin, which in turn prevents release of iron from its stores. The process is mediated by blocking iron channels (such as ferroportin). Inflammatory cytokines also appear to influence other important aspects of iron metabolism, such as decreasing ferroportin expression, and possibly directly suppressing erythropoiesis by decreasing the ability of the bone marrow to respond to erythropoietin [124] .
The present study indicated a higher (92.8%) CMV IgG seroprevalence in women exposed compared to those who not exposed (90.4%) to animals, however, the difference was not significant. There was no report present in the literature that described the association between animal exposure and CMV infection. While CMV is considered to be species specific, research group previously showed that baboon CMV can replicate on human fibroblasts in vitro [125] . The high positivity in exposed as compared to none exposed to animals may be due to presence of cross reactivity between HCMV and animal CMV.
CMV IgG seroprevalence was significantly (X 2 =6.1, P=0.01) lower (89.5%) in women with frequent abortion (3-8) as compared to women (97.4%) non frequent abortion (1-2) . OR confirmed the association between CMV IgG seroprevalence and number of abortion (OR=4.39, P=0.01). However, CMV IgG seroprevalence was higher (95.9%) in women with congenital anomalies pregnancy outcome as compared to those without (90.8%), but the difference not reach significant level (X 2 =.48, P>0.05). OR not confirmed as association between CMV IgG seroprevalence and development of congenital anomalies (OR=0.418, p>0.05).
The high rate of CMV seroprevalence in women with low number of abortion may be a reflection of the high viraemia in primary infection. Then CMV antibodies waned with time so the seropositivity reduced and demonstrate a low seroprevalence of CMV IgG. 
